Jacobs Levy Equity Management’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.08M Buy
289,385
+94,774
+49% +$959K 0.01% 511
2025
Q4
$1.83M Buy
+194,611
New +$1.52M 0.01% 596
2025
Q3
Sell
-13,501
Closed -$45.5K 1003
2025
Q2
$45.5K Sell
13,501
-3,981
-23% -$14.9K ﹤0.01% 1017
2025
Q1
$67.5K Sell
17,482
-779
-4% -$3.72K ﹤0.01% 1054
2024
Q4
$113K Sell
18,261
-262,010
-93% -$1.52M ﹤0.01% 916
2024
Q3
$1.51M Sell
280,271
-195,987
-41% -$922K 0.01% 658
2024
Q2
$1.6M Sell
476,258
-25,762
-5% -$100K 0.01% 645
2024
Q1
$2.02M Sell
502,020
-47,098
-9% -$126K 0.01% 596
2023
Q4
$1.46M Buy
+549,118
New +$1.26M 0.01% 658
2023
Q3
Sell
-16,100
Closed -$101K 987
2023
Q2
$101K Buy
+16,100
New +$98.5K ﹤0.01% 946

Other funds holding DSGN